Alison J. Foster

1.9k citations

23 papers · 1.1k indexed · h-index 16

Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 16
- Drug-Induced Hepatotoxicity and Protection 15
Hepatology top 5%
- Liver physiology and pathology 4
- Hepatocellular Carcinoma Treatment and Prognosis 1
Computational Theory and Mathematics top 5%
Pharmaceutical Science top 5%
Biophysics top 10%
Oncology
- Drug Transport and Resistance Mechanisms 8
Biomedical Engineering
- Innovative Microfluidic and Catalytic Techniques Innovation 1
Biotechnology
- Cancer Research and Treatments 1
Cancer Research
- Cancer, Hypoxia, and Metabolism 1

Co-authors: J. Gerry Kenna Dominic P. Williams Paul Morgan Brian Middleton Stanley E. Lazic William R. Proctor Mark Pilling Simon Ströbel
Cited by: Pharmacology Hepatology Computational Theory and Mathematics
Partner nations: United Kingdom Sweden United States

In The Last Decade

Alison J. Foster

22 papers receiving 1.0k citations

Peers

Countries citing papers authored by Alison J. Foster

Since Specialization

Citations

This map shows the geographic impact of Alison J. Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison J. Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison J. Foster more than expected).

Fields of papers citing papers by Alison J. Foster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison J. Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison J. Foster. The network helps show where Alison J. Foster may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alison J. Foster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alison J. Foster Line = papers co-authored together Alison J. Foster links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Use of new approach methodology for hepatic safety assessment of covalent inhibitor drug candidates Sara Amberntsson,Alison J. Foster,Bhavik Chouhan,Stephen Wilkinson,Stephanie Harlfinger,G. Smith,Jason G. Kettle,Michael Niedbala,Stefan Kavanagh,Dominic P. Williams	2025	0
2	Introducing an automated high content confocal imaging approach for Organs-on-Chips S Peel,Adam Corrigan,Beate Ehrhardt,Kyung‐Jin Jang,Pedro Caetano-Pinto,Matthew Boeckeler,Jonathan E. Rubins,Konstantia Kodella,Debora B. Petropolis,Janey Ronxhi,Gauri Kulkarni,Alison J. Foster,Dominic P. Williams,Geraldine A. Hamilton,Lorna Ewart	2019	73
3	Analysis of β-catenin gene mutations and gene expression in liver tumours of C57BL/10J mice produced by chronic administration of sodium phenobarbital James E. Sidaway,Terry C. Orton,Kassiani Kalaitzi,Huw B. Jones,Alison J. Foster,Brian G. Lake	2019	6
4	Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid Alison J. Foster,Bhavik Chouhan,Sophie Regan,Helen Rollison,Sara Amberntsson,Linda C. Andersson,Abhishek Srivastava,Malin Darnell,Jonathan Cairns,Stanley E. Lazic,Kyung‐Jin Jang,Debora B. Petropolis,Konstantia Kodella,Jonathan E. Rubins,Dominic P. Williams,Geraldine A. Hamilton,Lorna Ewart,Paul Morgan	2019	85
5	Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury William R. Proctor,Alison J. Foster,Jennifer Vogt,Claire Summers,Brian Middleton,Mark Pilling,Daniel Shienson,Monika Kijańska,Simon Ströbel,Jens M. Kelm,Paul Morgan,Simon Messner,Dominic P. Williams	2017	219
6	Cytotoxicity evaluation using cryopreserved primary human hepatocytes in various culture formats Lysiane Richert,Audrey Baze,C. Parmentier,Helga H.J. Gerets,Rowena Sison‐Young,M Dorau,Cerys Lovatt,Andreas Czich,Christopher E. Goldring,B. Kevin Park,Satu Juhila,Alison J. Foster,Dominic P. Williams	2016	18
7	Improved hepatic physiology in hepatic cytochrome P450 reductase null (HRN™) mice dosed orally with fenclozic acid James Akingbasote,Alison J. Foster,Huw B. Jones,Rhiannon David,Nigel J. Gooderham,Ian D. Wilson,J. Gerry Kenna	2016	1
8	Hepatic effects of repeated oral administration of diclofenac to hepatic cytochrome P450 reductase null (HRN™) and wild-type mice James Akingbasote,Alison J. Foster,Ian D. Wilson,Sunil Sarda,Huw B. Jones,J. Gerry Kenna	2015	5
9	Multiple Compound-Related Adverse Properties Contribute to Liver Injury Caused by Endothelin Receptor Antagonists J. Gerry Kenna,Simone H. Stahl,Julie Eakins,Alison J. Foster,Linda C. Andersson,Jonas Bergare,Martin Billger,Marie Elebring,Charles S. Elmore,Richard A. Thompson	2014	35
10	A comparison of the metabolism of midazolam in C57BL/6J and hepatic reductase null (HRN) mice Aidan Grimsley,Alison J. Foster,Richard T. Gallagher,Michael G. Hutchison,Anders Lundqvist,Kathryn Pickup,Ian D. Wilson,Kristin Samuelsson	2014	5
11	Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytes Helen Garside,Karen F. Marcoe,Jessica Chesnut-Speelman,Alison J. Foster,Daniel Muthas,J. Gerry Kenna,Usha Warrior,Joanne Bowes,James E. Baumgartner	2013	74
12	A Correlation Between the In Vitro Drug Toxicity of Drugs to Cell Lines That Express Human P450s and Their Propensity to Cause Liver Injury in Humans Frida Gustafsson,Alison J. Foster,Sunil Sarda,Matthew Bridgland‐Taylor,J. Gerry Kenna	2013	57
13	Glutathione metabolism modeling: A mechanism for liver drug-robustness and a new biomarker strategy Suzanne Geenen,Franco B. du Preez,Jacky L. Snoep,Alison J. Foster,Sunil Sarda,J. Gerry Kenna,Ian D. Wilson,Hans V. Westerhoff	2013	30
14	Characterization of THLE-Cytochrome P450 (P450) Cell Lines: Gene Expression Background and Relationship to P450-Enzyme Activity Yalda Soltanpour,Constanze Hilgendorf,Marie M. Ahlström,Alison J. Foster,J. Gerry Kenna,Anne Petersen,Anna‐Lena Ungell	2012	15
15	In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs Richard A. Thompson,Emre M. Isin,Yan Li,Lars Weidolf,Ken Page,Ian D. Wilson,Steve Swallow,Brian Middleton,Simone H. Stahl,Alison J. Foster,Hugues Dolgos,Richard Weaver,J. Gerry Kenna	2012	153
16	Bioactivation of the Cannabinoid Receptor Antagonist Rimonabant to a Cytotoxic Iminium Ion Metabolite Alison J. Foster,Lucy H. Prime,Frida Gustafsson,David G. Temesi,Emre M. Isin,Johanna Midlöv,Neal Castagnoli,J. Gerry Kenna	2012	17
17	In vitro investigation of the role of cyp dependent metabolism in drug hepatotoxicity using the THLE-CYP cell panel Alison J. Foster,Mhairi L. Greer,Rebecca Coates,Tim J.D. Smith,J. Gerry Kenna	2010	3
18	Systematic tuning of pore morphologies and pore volumes in macroporous materials by freezing Lei Qian,Adham Ahmed,Alison J. Foster,Steve P. Rannard,Andrew I. Cooper,Haifei Zhang	2009	49
19	Identification of potent and selective oxytocin antagonists. Part 1: indole and benzofuran derivatives Paul G. Wyatt,Michael Allen,Josie Chilcott,Alison J. Foster,David G. Livermore,Jackie E. Mordaunt,Jan Scicinski,P.M. Woollard	2002	27
20	The rôle of thymidine phosphorylase/PD-ECGF in cancer chemotherapy: a chemical perspective. Christian Cole,Alison J. Foster,Sally Freeman,Mohammed Jaffar,Paul E. Murray,Ian J. Stratford	1999	18

About Alison J. Foster

Alison J. Foster is a scholar working on Pharmacology, Hepatology and Oncology, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Drug-Induced Hepatotoxicity and Protection (15 papers), Drug Transport and Resistance Mechanisms (8 papers), Liver physiology and pathology (4 papers), Innovative Microfluidic and Catalytic Techniques Innovation (1 paper), Cancer Research and Treatments (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Pharmacology (418 citations), Hepatology (239 citations) and Computational Theory and Mathematics (156 citations). Alison J. Foster has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include J. Gerry Kenna, Dominic P. Williams, Paul Morgan, Brian Middleton, Stanley E. Lazic, William R. Proctor, Mark Pilling, Simon Ströbel, Jens M. Kelm and Simon Messner.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact